ALMS (Alumis) Marketable Securities: $459.06 Mil (As of Mar. 2026)


ALMS Alumis Inc ALMS
12 GF Score
Price $26.50
! 4 Warning Signs
View Full Analysis

What is Alumis Marketable Securities?

Alumis ALMS -0.53% 12 Marketable Securities is $459.06 Mil as of Mar. 2026. GuruFocus rates ALMS with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Alumis's Marketable Securities for the quarter that ended in Mar. 2026 was $459.06 Mil.

Alumis's annual Marketable Securities increased from Dec. 2023 ($2.96 Mil) to Dec. 2024 ($118.74 Mil) and increased from Dec. 2024 ($118.74 Mil) to Dec. 2025 ($218.83 Mil).

Alumis  (NAS:ALMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Alumis Marketable Securities Related Terms

Alumis Marketable Securities Historical Data

* Premium members only.

The historical data trend for Alumis's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alumis Marketable Securities Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
67.26 2.96 118.74 218.83

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.21 334.57 312.47 218.83 459.06
ALMS
12GF Score
Alumis Inc ALMS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alumis Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $459.06 Mil mean?
Alumis (ALMS) has a Marketable Securities of $459.06 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Alumis and its competitors.
Is Alumis' Marketable Securities too high?
Alumis' current Marketable Securities is $459.06 Mil. Overall, Alumis has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alumis' Marketable Securities compare to ARQT and QURE?
Alumis' Marketable Securities of $459.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Alumis and its competitors. Alumis's current Marketable Securities is $459.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alumis stock overvalued right now?
Alumis (ALMS) has a current Marketable Securities of $459.06 Mil. The current Marketable Securities is $459.06 Mil. Alumis' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Alumis (ALMS), the current Marketable Securities is $459.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alumis Business Description

Address 280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
12GF Score

Get the complete analysis for ALMS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.50
Price